NCAPG and cancer: Through analysis of the OS, RFS, PFS, and DSS of NCAPG in human cancer, NCAPG may be used for an unfavorable prognostic biomarker in patients with ACC, KIRC, KIRP, LGG, LIHC, LUAD, MESO, PAAD, PCPG, and SARC.